Recent and future advances in intracerebral hemorrhage

Area of Science:

• Neurology
• Vascular Medicine

Background:

• Spontaneous intracerebral hemorrhage (ICH) is a severe stroke subtype with high mortality.
• ICH accounts for nearly 30% of all strokes globally, affecting 3.5 million people annually.
• Survivors often face significant long-term functional deficits.

Purpose of the Study:

• To review the pathophysiology, diagnosis, and current management strategies for intracerebral hemorrhage.
• To highlight the importance of early intervention and explore emerging therapeutic avenues.
• To discuss secondary prevention challenges in ICH survivors.

Main Methods:

• Literature review of intracerebral hemorrhage pathophysiology and clinical management.
• Analysis of diagnostic work-up, including advanced imaging techniques.
• Evaluation of therapeutic interventions and secondary prevention strategies.

Main Results:

• ICH involves dynamic processes including hematoma expansion and secondary brain injury.
• Early management focusing on blood pressure control and anticoagulant reversal is vital.
• Emerging therapies aim to reduce hemorrhage expansion, facilitate surgical evacuation, and mitigate secondary injury.

Conclusions:

• Prompt diagnosis and timely intervention are critical for improving outcomes in intracerebral hemorrhage.
• While specific treatments are evolving, current strategies focus on managing complications and risks.
• Optimizing secondary prevention requires individualized risk-benefit assessments for ICH survivors.